FIGURE
Fig. 4
- ID
- ZDB-FIG-250610-10
- Publication
- Gundersen et al., 2025 - Repurposing chlorpromazine for anti-leukaemic therapy with the drug-in-cyclodextrin-in-liposome nanocarrier platform
- Other Figures
- All Figure Page
- Back to All Figure Page
Fig. 4
DRV formulations demonstrate CD-dependent cell death kinetics. MOLM-13 cells were incubated for up to 12 h with 100 μM chlorpromazine (CPZ) in either free or encapsulated form, or empty (dehydration-rehydration vesicles) DRV of equivalent lipid concentration, before being fixed and stained with 2 % formaldehyde (in pH 7.4 PBS) containing 0.005 mg/mL Hoechst33342. Nuclei-stained cells were imaged with an Axiovert 200M fluorescence microscopy and counted for apoptosis. The results are shown as the mean ± SD of a triplicate experiment. |
Expression Data
Expression Detail
Antibody Labeling
Phenotype Data
Phenotype Detail
Acknowledgments
This image is the copyrighted work of the attributed author or publisher, and
ZFIN has permission only to display this image to its users.
Additional permissions should be obtained from the applicable author or publisher of the image.
Full text @ Carbohydr. Polym.